177 related articles for article (PubMed ID: 26648169)
1. A20 regulates IL-1-induced tolerant production of CXC chemokines in human mesangial cells via inhibition of MAPK signaling.
Luo H; Liu Y; Li Q; Liao L; Sun R; Liu X; Jiang M; Hu J
Sci Rep; 2015 Dec; 5():18007. PubMed ID: 26648169
[TBL] [Abstract][Full Text] [Related]
2. TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via A20 inhibition of ERK signaling.
Zhou X; An D; Liu X; Jiang M; Yuan C; Hu J
Int Immunopharmacol; 2018 Jan; 54():296-302. PubMed ID: 29175508
[TBL] [Abstract][Full Text] [Related]
3. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
4. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells.
Awane M; Andres PG; Li DJ; Reinecker HC
J Immunol; 1999 May; 162(9):5337-44. PubMed ID: 10228009
[TBL] [Abstract][Full Text] [Related]
5. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.
Zou XL; Pei DA; Yan JZ; Xu G; Wu P
Int J Mol Sci; 2014 Apr; 15(4):6592-608. PubMed ID: 24747594
[TBL] [Abstract][Full Text] [Related]
6. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
8. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20.
Das S; Pandey K; Kumar A; Sardar AH; Purkait B; Kumar M; Kumar S; Ravidas VN; Roy S; Singh D; Das P
Immunol Cell Biol; 2012 Jul; 90(6):640-54. PubMed ID: 21968712
[TBL] [Abstract][Full Text] [Related]
10. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine.
Breckpot K; Aerts-Toegaert C; Heirman C; Peeters U; Beyaert R; Aerts JL; Thielemans K
J Immunol; 2009 Jan; 182(2):860-70. PubMed ID: 19124729
[TBL] [Abstract][Full Text] [Related]
11. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
13. A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cells.
Hu J; Wang G; Liu X; Zhou L; Jiang M; Yang L
PLoS One; 2014; 9(1):e87528. PubMed ID: 24489933
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of interleukin-1 receptor type 1 expression causes the dysregulated expression of CXC chemokines in endometriotic stromal cells: a possible mechanism for the altered immunological functions in endometriosis.
Nishida M; Nasu K; Fukuda J; Kawano Y; Narahara H; Miyakawa I
J Clin Endocrinol Metab; 2004 Oct; 89(10):5094-100. PubMed ID: 15472211
[TBL] [Abstract][Full Text] [Related]
15. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
Lee SA; Fitzgerald SM; Huang SK; Li C; Chi DS; Milhorn DM; Krishnaswamy G
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):283-91. PubMed ID: 15191916
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
[TBL] [Abstract][Full Text] [Related]
18. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB.
Wong CK; Tsang CM; Ip WK; Lam CW
Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136
[TBL] [Abstract][Full Text] [Related]
20. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
